PAION AG announced that Hana Pharm informed PAION about the launch of Byfavo™ (remimazolam) for the use in general anesthesia in South Korea. Remimazolam was approved in South Korea for general anesthesia in January 2021 and will be marketed under the brand name Byfavo™.